Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne

References

• An JS, Kim JE, Lee DH, Kim BY, Cho S, Kwon IH, et al. 2011. 0.5% Liposome-encapsulated 5-aminolevulinic acid (ALA) photodynamic therapy for acne treatment. J Cosmet Laser Ther. 13:28–32.
   PubMed Web of Science ®Google Scholar
• Bettoli V, Sarno O, Zauli S, Borghi A, Minghetti S, Ricci M, et al. 2010. [What's new in acne? New therapeutic approaches]. Ann Dermatol Venereol. 137 Suppl 2:S81–S85.
   PubMed Web of Science ®Google Scholar
• Borges VR, Simon A, Sena AR, Cabral LM, de Sousa VP. 2013. Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation. Int J Nanomedicine. 8:535–544.
   PubMed Web of Science ®Google Scholar
• Brown EJ. 1977. A povidone-iodine skin cleanser foam in the management of acne vulgaris. Br J Clin Pract. 31:218–219.
   PubMedGoogle Scholar
• Castro GA, Ferreira LA. 2008. Novel vesicular and particulate drug delivery systems for topical treatment of acne. Expert Opin Drug Deliv. 5:665–679.
   PubMed Web of Science ®Google Scholar
• Castro GA, Oliveira CA, Mahecha GA, Ferreira LA. 2011. Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne. Arch Dermatol Res. 303:513–520.
   PubMed Web of Science ®Google Scholar
• Castro GA, Orefice RL, Vilela JM, Andrade MS, Ferreira LA. 2007. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J Microencapsul. 24:395–407.
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ. 2009. The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. J Clin Aesthet Dermatol. 2:26–29.
   Google Scholar
• Dominguez-Delgado CL, Rodriguez-Cruz IM, Escobar-Chavez JJ, Calderon-Lojero IO, Quintanar-Guerrero D, Ganem A. 2011. Preparation and characterization of triclosan nanoparticles intended to be used for the treatment of acne. Eur J Pharm Biopharm. 79:102–107.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Hebert AA, Schachner L, Paller AS, Rossi AB, Lucky AW. 2012. Tretinoin microsphere gel 0.04% pump for treating acne vulgaris in preadolescents: a randomized, controlled study. Pediatr Dermatol. 29:598–604.
   PubMed Web of Science ®Google Scholar
• Fireman S, Toledano O, Neimann K, Loboda N, Dayan N. 2011. A look at emerging delivery systems for topical drug products. Dermatol Ther. 24:477–488.
   PubMed Web of Science ®Google Scholar
• Fluhr JW, Barsom O, Gehring W, Gloor M. 1999. Antibacterial efficacy of benzoyl peroxide in phospholipid liposomes. A vehicle-controlled, comparative study in patients with papulopustular acne. Dermatology. 198:273–277.
   PubMed Web of Science ®Google Scholar
• Fu LW, Vender RB. 2011. Newer approaches in topical combination therapy for acne. Skin Therapy Lett. 16:3–6.
   PubMedGoogle Scholar
• Garg T, Singh O, Arora S, Murthy R. 2012. Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst. 29:1–63.
   PubMed Web of Science ®Google Scholar
• Garg T, Singh S, Goyal AK. 2013. Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst. 30:369–409.
   PubMed Web of Science ®Google Scholar
• Honzak L, Sentjurc M. 2000. Development of liposome encapsulated clindamycin for treatment of acne vulgaris. Pflugers Arch. 440: R44–R45.
   PubMed Web of Science ®Google Scholar
• Inui S, Aoshima H, Ito M, Kobuko K, Itami S. 2012. Inhibition of sebum production and Propionibacterium acnes lipase activity by fullerenol, a novel polyhydroxylated fullerene: potential as a therapeutic reagent for acne. J Cosmet Sci. 63:259–265.
   PubMed Web of Science ®Google Scholar
• Inui S, Aoshima H, Nishiyama A, Itami S. 2011. Improvement of acne vulgaris by topical fullerene application: unique impact on skin care. Nanomedicine. 7:238–241.
   PubMed Web of Science ®Google Scholar
• Jelvehgari M, Siahi-Shadbad MR, Azarmi S, Martin GP, Nokhodchi A. 2006. The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies. Int J Pharm. 308: 124–132.
   PubMed Web of Science ®Google Scholar
• Kaur N, Puri R, Jain SK. 2010. Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent. AAPS PharmSciTech. 11:528–537.
   PubMed Web of Science ®Google Scholar
• Kim W, Mancini AJ. 2013. Acne in childhood: an update. Pediatr Ann. 42:418–427.
   PubMed Web of Science ®Google Scholar
• Kircik LH. 2011. Microsphere technology: hype or help?J Clin Aesthet Dermatol. 4:27–31.
   PubMedGoogle Scholar
• Kumar A, Agarwal SP, Ahuja A, Ali J, Choudhry R, Baboota S. 2011. Preparation, characterization, and in vitro antimicrobial assessment of nanocarrier based formulation of nadifloxacin for acne treatment. Pharmazie. 66:111–114.
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Tanghetti EA, Miller B, Ung M, Berson D, Lee J. 2002. Once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.1% microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial. Cutis. 69:12–19.
   PubMedGoogle Scholar
• Leyden J, Wortzman M, Baldwin EK. 2009. Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel. J Drugs Dermatol. 8:383–388.
   PubMed Web of Science ®Google Scholar
• Lin CH, Fang YP, Al-Suwayeh SA, Yang SY, Fang JY. 2013. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment. Biol Pharm Bull. 36:276–286.
   PubMed Web of Science ®Google Scholar
• Liu CH, Huang HY. 2012. Antimicrobial activity of curcumin-loaded myristic acid microemulsions against Staphylococcus epidermidis. Chem Pharm Bull (Tokyo). 60:1118–1124.
   PubMed Web of Science ®Google Scholar
• Liu CH, Huang HY. 2013. In vitro anti-propionibacterium activity by curcumin containing vesicle system. Chem Pharm Bull (Tokyo). 61:419–425.
   PubMed Web of Science ®Google Scholar
• Lolis MS, Bowe WP, Shalita AR. 2009. Acne and systemic disease. Med Clin North Am. 93:1161–1181.
   PubMed Web of Science ®Google Scholar
• Lucky AW, Sugarman J. 2011. Comparison of micronized tretinoin gel 0.05% and tretinoin gel microsphere 0.1% in young adolescents with acne: a post hoc analysis of efficacy and tolerability data. Cutis. 87:305–310.
   PubMed Web of Science ®Google Scholar
• Parnami N, Garg T, Rath G, Goyal AK. 2013. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol. (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Patwardhan SV, Kaczvinsky JR, Joa JF, Canfield D. 2013. Auto- classification of acne lesions using multimodal imaging. J Drugs Dermatol. 12:746–756.
   PubMed Web of Science ®Google Scholar
• Pauli SL, Reunala T. 1987. [Acne fulminans—a systemic disease refractory to treatment]. Duodecim. 103:835–839.
   PubMedGoogle Scholar
• Pornpattananangkul D, Fu V, Thamphiwatana S, Zhang L, Chen M, Vecchio J, et al. 2013. In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids. Adv Healthc Mater. 2:1322–1328.
   PubMed Web of Science ®Google Scholar
• Prasad S, Mukhopadhyay A, Kubavat A, Kelkar A, Modi A, Swarnkar B, et al. 2012. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial. Indian J Dermatol Venereol Leprol. 78:459–467.
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Singal P, Wadhwa S, Katare OP. 2013. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf B Biointerfaces. 105:67–74.
   PubMed Web of Science ®Google Scholar
• Ridolfi DM, Marcato PD, Justo GZ, Cordi L, Machado D, Duran N. 2012. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Colloids Surf B Biointerfaces. 93:36–40.
   PubMed Web of Science ®Google Scholar
• Rolland A, Wagner N, Chatelus A, Shroot B, Schaefer H. 1993. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res. 10:1738–1744.
   PubMed Web of Science ®Google Scholar
• Schafer-Korting M, Korting HC, Ponce-Poschl E. 1994. Liposomal tretinoin for uncomplicated acne vulgaris. Clin Investig. 72: 1086–1091.
   PubMedGoogle Scholar
• Shah KA, Joshi MD, Patravale VB. 2009. Biocompatible microemulsions for fabrication of glyceryl monostearate solid lipid nanoparticles (SLN) of tretinoin. J Biomed Nanotechnol. 5: 396–400.
   PubMed Web of Science ®Google Scholar
• Simonart T. 2012. Newer approaches to the treatment of acne vulgaris. Am J Clin Dermatol. 13:357–364.
   PubMed Web of Science ®Google Scholar
• Tanghetti EA. 2013. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol. 6:27–35.
   PubMedGoogle Scholar
• Vender R. 2012. Double-blinded, vehicle-controlled proof of concept study to investigate the recurrence of inflammatory and noninflammatory acne lesions using tretinoin gel (microsphere) 0.04% in male patients after oral isotretinoin use. Dermatol Res Pract. 2012:736532.
   PubMedGoogle Scholar
• Viyoch J, Pisutthanan N, Faikreua A, Nupangta K, Wangtorpol K, Ngokkuen J. 2006. Evaluation of in vitro antimicrobial activity of Thai basil oils and their micro-emulsion formulas against Propionibacterium acnes. Int J Cosmet Sci. 28:125–133.
   PubMedGoogle Scholar
• Well D. 2013. Acne vulgaris: a review of causes and treatment options. Nurse Pract. 38:22–31.
   PubMedGoogle Scholar
• Williams HC, Dellavalle RP, Garner S. 2012. Acne vulgaris. Lancet. 379:361–372.
   PubMed Web of Science ®Google Scholar
• Yeung CK, Shek SY, Yu CS, Kono T, Chan HH. 2011. Liposome- encapsulated 0.5% 5-aminolevulinic acid with intense pulsed light for the treatment of inflammatory facial acne: a pilot study. Dermatol Surg. 37:450–459.
   PubMed Web of Science ®Google Scholar